Literature DB >> 3385445

Cerebellar dysfunction in patients with bronchogenic carcinoma: clinical and posturographic findings.

K Wessel1, H C Diener, J Dichgans, A Thron.   

Abstract

Neurological examination and posturography showed cerebellar signs in 13 of 50 unselected patients with bronchogenic carcinoma not complicated by other diseases. The occurrence of cerebellar signs did not depend on the histological type of tumour or the extent of tumour spread. Most of the clinically affected patients had mild to pronounced cerebellar atrophy, revealed by CT. The correlation between the amount of CT-confirmed atrophy and the severity of clinical symptoms, however, was poor. Since other reasons for cerebellar dysfunction (e.g. chemotherapy, chronic alcoholism, metastases) were excluded, cerebellar signs were attributed to paraneoplastic cerebellar degeneration or to a consequence of severe neoplastic illness. The high incidence of cerebellar dysfunction in patients with bronchogenic carcinoma confirms the frequent histopathological finding of cortical cerebellar degeneration in malignant disease.

Entities:  

Mesh:

Year:  1988        PMID: 3385445     DOI: 10.1007/bf00314176

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  21 in total

1.  Subacute cortical cerebellar degeneration and its relation to carcinoma.

Authors:  W R BRAIN; P M DANIEL; J G GREENFIELD
Journal:  J Neurol Neurosurg Psychiatry       Date:  1951-05       Impact factor: 10.154

2.  The course and prognosis in some types of carcinomatous neuromyopathy.

Authors:  P B Croft; M Wilkinson
Journal:  Brain       Date:  1969-03       Impact factor: 13.501

3.  Subacute cerebellar degeneration associated with neoplasms.

Authors:  L Brain; M Wilkinson
Journal:  Brain       Date:  1965-09       Impact factor: 13.501

4.  Nonmetastatic neurological complications of bronchogenic carcinoma: the carcinomatous neuromyopathies.

Authors:  D L Morton; H H Itabashi; O F Grimes
Journal:  J Thorac Cardiovasc Surg       Date:  1966-01       Impact factor: 5.209

5.  Atrophy of the cerebellar vermis in ageing. A morphometric and histologic study.

Authors:  A Torvik; S Torp; C F Lindboe
Journal:  J Neurol Sci       Date:  1986-12       Impact factor: 3.181

6.  Paraneoplastic cerebellar disease. Remission with excision of the primary tumor.

Authors:  J H Kearsley; P Johnson; G M Halmagyi
Journal:  Arch Neurol       Date:  1985-12

7.  Elderly inpatients: postural reflex impairment.

Authors:  W J Weiner; L M Nora; R H Glantz
Journal:  Neurology       Date:  1984-07       Impact factor: 9.910

8.  Autoimmune response of patients with paraneoplastic cerebellar degeneration to a Purkinje cell cytoplasmic protein antigen.

Authors:  K A Jaeckle; F Graus; A Houghton; C Cardon-Cardo; S L Nielsen; J B Posner
Journal:  Ann Neurol       Date:  1985-11       Impact factor: 10.422

9.  Improvement of ataxia in alcoholic cerebellar atrophy through alcohol abstinence.

Authors:  H C Diener; J Dichgans; M Bacher; B Guschlbauer
Journal:  J Neurol       Date:  1984       Impact factor: 4.849

10.  Correlation of clinical signs with CT findings in patients with cerebellar disease.

Authors:  H C Diener; A Müller; A Thron; M Poremba; J Dichgans; H Rapp
Journal:  J Neurol       Date:  1986-02       Impact factor: 4.849

View more
  3 in total

1.  Significance of MRI-confirmed atrophy of the cranial spinal cord in Friedreich's ataxia.

Authors:  K Wessel; G Schroth; H C Diener; W Müller-Forell; J Dichgans
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1989

2.  Cerebellar dysfunction in patients with bronchogenic carcinoma: immunological investigations.

Authors:  K Wessel; C Budde-Steffen; H Wiethölter; H C Diener; J Dichgans
Journal:  J Neurol       Date:  1988-05       Impact factor: 4.849

3.  Misclassification of patients with spinocerebellar ataxia as having psychogenic postural instability based on computerized dynamic posturography.

Authors:  Susan J Herdman; Courtney D Hall; Rachael Eggers; Stasha Sampson; Sydne Goodier; Becky Filson
Journal:  Front Neurol       Date:  2011-04-04       Impact factor: 4.003

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.